Single-Use Ophthalmic Surgical Devices

Global Single-Use Ophthalmic Surgical Devices Market to Reach US$10.8 Billion by 2030

The global market for Single-Use Ophthalmic Surgical Devices estimated at US$7.7 Billion in the year 2024, is expected to reach US$10.8 Billion by 2030, growing at a CAGR of 5.7% over the analysis period 2024-2030. Forceps, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$2.7 Billion by the end of the analysis period. Growth in the Speculum segment is estimated at 4.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.1 Billion While China is Forecast to Grow at 8.9% CAGR

The Single-Use Ophthalmic Surgical Devices market in the U.S. is estimated at US$2.1 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.2 Billion by the year 2030 trailing a CAGR of 8.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.8% and 5.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Global Single Use Ophthalmic Surgical Devices Market – Key Trends & Drivers Summarized

Why Are Single Use Ophthalmic Surgical Devices Gaining Popularity? Examining Their Role in Modern Eye Surgeries

The ophthalmic surgery sector has witnessed a significant shift toward single-use surgical devices due to the increasing emphasis on patient safety, infection control, and cost-effective healthcare solutions. Single-use ophthalmic surgical devices, including disposable forceps, scalpels, cannulas, and intraocular lens injectors, have become essential in procedures such as cataract surgery, glaucoma treatment, and corneal transplants. These devices eliminate the risk of cross-contamination and hospital-acquired infections (HAIs), which have become a growing concern in surgical settings. With ophthalmic procedures requiring extreme precision and sterility, the adoption of disposable surgical tools ensures that each procedure is performed with fresh, contamination-free instruments. Additionally, the increasing global prevalence of eye disorders, such as age-related macular degeneration (AMD) and diabetic retinopathy, has fueled the demand for efficient and safe surgical interventions. The rise in outpatient ophthalmic surgeries has further accelerated the use of single-use devices, allowing clinics and ambulatory surgical centers to maintain high safety standards while reducing operational complexities associated with reusable instruments.

How Are Technological Advancements Improving Single Use Ophthalmic Devices? Exploring Innovations in Material Science and Precision Engineering

Technological advancements in material science, miniaturization, and ergonomic design have significantly enhanced the performance and efficiency of single-use ophthalmic surgical devices. The development of high-quality polymer-based disposable instruments has improved durability and flexibility, allowing surgeons to perform delicate procedures with greater precision. Additionally, the integration of micro-engineered blades and ultra-thin cannulas has minimized tissue trauma, leading to faster patient recovery times. The rise of preloaded intraocular lens (IOL) injectors has streamlined cataract surgery by reducing handling time and enhancing surgical accuracy. Furthermore, the incorporation of ergonomic grip designs and anti-slip coatings has improved surgeon control, reducing fatigue and enhancing procedural outcomes. Recent innovations have also focused on eco-friendly single-use surgical tools, with manufacturers exploring biodegradable materials to address environmental concerns associated with disposable medical waste. As the demand for precision, safety, and efficiency in ophthalmic surgeries continues to grow, technological advancements are driving the development of next-generation single-use surgical devices tailored to modern surgical needs.

What Challenges Are Hindering the Widespread Adoption of Single Use Ophthalmic Surgical Devices? Addressing Market Constraints and Regulatory Barriers

Despite their numerous advantages, the adoption of single-use ophthalmic surgical devices faces several challenges, including cost concerns, environmental impact, and regulatory complexities. While disposable instruments reduce sterilization costs and the risk of infections, their higher upfront costs compared to reusable alternatives can be a deterrent for budget-conscious hospitals and surgical centers. The recurring expenses associated with purchasing disposable tools for every procedure may create financial strain, particularly in resource-limited healthcare settings. Additionally, the environmental impact of medical waste generated by single-use devices has raised sustainability concerns, prompting regulatory bodies and healthcare institutions to explore waste management solutions. Stricter environmental regulations in regions such as the European Union have led to increased scrutiny of disposable medical devices, requiring manufacturers to develop more sustainable materials and recycling programs. Furthermore, variations in regulatory approval processes across different regions create challenges for global market expansion, as manufacturers must comply with varying standards for device safety and efficacy. Overcoming these challenges requires a balance between cost-effectiveness, sustainability, and regulatory compliance to ensure widespread adoption of single-use ophthalmic surgical devices.

What’s Driving the Growth of the Single Use Ophthalmic Surgical Devices Market? Identifying Key Expansion Factors and Industry Trends

The growth in the single use ophthalmic surgical devices market is driven by several factors, including the increasing prevalence of ophthalmic disorders, rising demand for outpatient surgical procedures, advancements in precision surgery, and stringent infection control regulations. The growing geriatric population has led to a surge in age-related eye conditions, such as cataracts and glaucoma, driving the need for safer and more efficient surgical solutions. Additionally, the shift toward ambulatory surgical centers and day-care ophthalmic procedures has increased the adoption of disposable instruments, as they offer a cost-effective and time-saving alternative to reusable tools. The advancement of minimally invasive ophthalmic surgery techniques, including femtosecond laser-assisted procedures and micro-incision surgeries, has further fueled demand for specialized single-use devices that enhance surgical precision. Moreover, regulatory bodies such as the FDA and WHO have enforced stringent sterilization and infection control guidelines, encouraging healthcare facilities to transition from reusable to disposable surgical tools. The increasing focus on sustainability has also prompted manufacturers to develop eco-friendly single-use ophthalmic devices, balancing safety with environmental responsibility. As patient safety, technological innovation, and regulatory compliance continue to drive the market, the adoption of single-use ophthalmic surgical devices is expected to witness sustained growth, shaping the future of ophthalmic surgical interventions worldwide.

SCOPE OF STUDY:

The report analyzes the Single-Use Ophthalmic Surgical Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Product (Forceps, Speculum, Nucleus Rotators & Choppers, Curettes, Cannulas, Knives, OVD, Others); Application (Diabetic Retinopathy, Cataract Surgery, Glaucoma Surgery, Refractive Surgery, Corneal Surgery, Vitreo-Retinal Surgery, Others); End-Use (Hospitals, Ophthalmic Clinics, Ambulatory Surgery Centers, Others)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

• Alcon Inc.
• Allergan Plc
• Anodyne Surgical
• Bausch + Lomb Inc.
• Beaver-Visitec International
• BVI Medical
• Carl Zeiss Meditec AG
• Corza Medical
• Duckworth & Kent Ltd.
• Essilor International S.A.
• Haag-Streit Holding AG
• HASA OPTIX
• Henry Schein Medical
• Hoya Corporation
• Hurricane Medical
• Johnson & Johnson Vision Care Inc.
• Marco Lombart
• Medicel AG
• MicroSurgical Technology
• Moria SA
• Nidek Co. Ltd.
• Oertli Instrumente AG
• Rhein Medical Inc.
• Speedway Surgical Co.
• STAAR Surgical Company
• Sterimedix®
• Storz® Ophthalmic Instruments
• Topcon Corporation
• Ziemer Ophthalmic Systems AG

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.